Clinical studies suggest that long-term exposure to COX-2 inhibitors known as coxibs may promote the initiation of cardiovascular disease (Jeong et al. 2020; Kang et al. 2020; Liao, et al. 2020). The gene discussed is PTGS2; the disease is cardiovascular disorder.